Facilitated percutaneous coronary intervention in patients with acute myocardial infarction transferred from remote hospitals

American Journal of Cardiology

Volumn 91, Issue 2, 2003, Pages 227-229

  Dudek, Dariusz ^a   Zmudka, Krzysztof ^a   Kałuza, Grzegorz L ^a   Kuta, Marcin ^a   Pienia̧zek, Piotr ^a   Przewłocki, Tadeusz ^a   Zorkun, Cafer ^a   Legutko, Jacek ^a   Gajos, Grzegorz ^a   Bartuś, Stanisław ^a   Bryniarski, Leszek ^a   Dziewierz, Artur ^a   Pasowicz, Mieczysław ^a   Dubiel, Jacek S ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ALTEPLASE; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; HEPARIN;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLEEDING; BYPASS SURGERY; CAUSE OF DEATH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DEATH; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEART ARRHYTHMIA; HEMODYNAMICS; HOSPITALIZATION; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; PATIENT TRANSPORT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; STROKE; SUDDEN DEATH; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIBODIES, MONOCLONAL; DRUG THERAPY, COMBINATION; FIBRINOLYTIC AGENTS; HEPARIN; HOSPITALS, COMMUNITY; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT TRANSFER; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0037298620     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(02)03112-0     Document Type: Article

References (10)

1. Grines C.L., Browne K.F., Marco J., Rothbaum D., Stone G.W., O'Keefe J., Overlie P., Donohue B., Chelliah N., Timmis G.C. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med. 328:1993;673-679.
2. Zijlstra F., Hoorntje J.C., de Boer M.J., Reiffers S., Miedema K., Ottervanger J.P., van'T Hof A.W., Suryapranata H. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med. 341:1999;1413-1419.
3. Widimsky P., Groch L., Zelizko M., Aschermann M., Bednar F., Suryapranata H. Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE study. Eur Heart J. 21:2000;823-831.
4. Ryan TJ, Antman EM, Brooks NH, Califf RM, Hillis LD, Hiratzka LF, Rapaport E, Riegel B, Russell RO, Smith EE III, et al. Update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Circulation 1999;100:1016-1030.
5. Grines C.L., Westerhausen D.R., Grines L.L., Hanlon J.T., Logemann T.L., Niemela M., Weaver W.D., Graham M., Boura J., O'Neill W.W., Balestrini C. A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction. The Air Primary Angioplasty in Myocardial Infarction Study. J Am Coll Cardiol. 39:2002;1713-1719.
6. Andersen HR. DANish Study in Acute Myocardial Infarction (DANAMI-II). Available at: http://www.clinicaltrialresults.org.
7. Cannon C.P., Gibson C.M., Lambrew C.T., Shoultz D.A., Levy D., French W.J., Gore J.M., Weaver W.D., Rogers W.J., Tiefenbrunn A.J. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA. 283:2000;2941-2947.
8. Ross A.M., Coyne K.S., Reiner J.S., Greenhouse S.W., Fink C., Frey A., Moreyra E., Traboulsi M., Racine N., Riba A.L., et al. A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction the PACT trial. PACT Investigators. Plasminogen-activator Angioplasty Compatibility Trial. J Am Coll Cardiol. 34:1999;1954-1962.
9. Herrmann H.C., Moliterno D.J., Ohman E.M., Stebbins A.L., Bode C., Betriu A., Forycki F., Miklin J.S., Bachinsky W.B., Lincoff A.M., Califf R.M., Topol E.J. Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction results from the SPEED (GUSTO-4 Pilot) Trial. J Am Coll Cardiol. 36:2000;1489-1496.
10. Stone G.W., Cox D., Garcia E., Brodie B.R., Morice M.C., Griffin J., Mattos L., Lansky A.J., O'Neill W.W., Grines C.L. Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction analysis from the Primary Angioplasty in Myocardial Infarction trials. Circulation. 104:2001;636-641.